Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Non-cell-autonomous cancer progression from chromosomal instability.

Li J. et al, (2023), Nature, 620, 1080 - 1088

The clinical and molecular significance associated with STING signaling in breast cancer.

Parkes EE. et al, (2021), NPJ Breast Cancer, 7

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Philippou Y. et al, (2020), Br J Cancer, 123, 1089 - 1100

Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation.

Phyu SM. and Smith TAD., (2019), Invest New Drugs, 37, 424 - 430

CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.

Phyu SM. et al, (2019), MAGMA, 32, 227 - 235

Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism.

Smith TAD. et al, (2017), Biomed Res Int, 2017

Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy: routes to glycogen synthase kinase 3.

Phyu SM. et al, (2016), Sci Rep, 6

Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.

Smith TAD. et al, (2016), Anticancer Res, 36, 87 - 93

Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.

Smith TAD. and Phyu SM., (2016), PLoS One, 11

Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.

Cooper AC. et al, (2015), J Cancer Res Clin Oncol, 141, 1523 - 1532